Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Ordinary Shares, par value 0.00001 NIS per share
-
Shares outstanding
-
240,356,213
-
Total 13F shares
-
82,827,477
-
Share change
-
+7,026,685
-
Total reported value
-
$989,795,174
-
Put/Call ratio
-
46%
-
Price per share
-
$11.95
-
Number of holders
-
146
-
Value change
-
+$84,273,008
-
Number of buys
-
83
-
Number of sells
-
69
Institutional Holders of Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) as of Q2 2024
As of 30 Jun 2024,
Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) was held by
146 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
82,827,477 shares.
The largest 10 holders included
True Wind Capital Management, L.P., Clal Insurance Enterprises Holdings Ltd, MORGAN STANLEY, Nine Ten Capital Management LLC, CROSSLINK CAPITAL INC, Phoenix Holdings Ltd., ACADIAN ASSET MANAGEMENT LLC, Voss Capital, LP, Greenhaven Road Investment Management, L.P., and FMR LLC.
This page lists
146
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.